NR1H4 and colitis: When FXR agonists such as INT-747 were used, the colitis induced by TNBS or DSS was significantly inhibited, the inflammatory infiltration was reduced [55], the intestinal permeability was decreased, and the loss of intestinal goblet cells and mucin was restored [72].